Page last updated: 2024-09-04

atrasentan and Neoplasm Metastasis

atrasentan has been researched along with Neoplasm Metastasis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	4 (44.44)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, AJ; Creel, P; George, DJ; Gockerman, JP; Haley, S; Hurwitz, H; Jaffe, TA; Moore, C; Petros, W; Sleep, D; Turnbull, J; Yenser, S	1
Fischgräbe, J; Götte, M; Kiesel, L; Michels, K; Wülfing, P	1
Buchanan, C; Lago Huvelle, MA; Peters, MG	1
Castelo, B; Espinosa, E; Merino, M; Pinto, A; Redondo, A; Zamora, P	1
de Gast, B; Giles, R; Groenewegen, G; Haanen, J; Vermaat, J; Voest, E; Walraven, M; Witteveen, E	1
Lee, D	1
Cella, D; Fishman, M; Mulani, P; Petrylak, DP; Teigland, C; Young, J	1
Kantoff, P; Kaufman, DS; Michaelson, MD; Oh, WK; Smith, MR	1
Bova, GS; Chan-Tack, K; Hedican, SP; Magnuson, SR; Nelson, JB; Opgenorth, TJ; Simons, JW	1

Reviews

3 review(s) available for atrasentan and Neoplasm Metastasis

Article	Year
Metastasis suppressors: basic and translational advances. Current pharmaceutical biotechnology, 2011, Volume: 12, Issue:11 Topics: Animals; Atrasentan; Endothelin-1; Genes, Tumor Suppressor; Humans; Neoplasm Metastasis; Pyrrolidines; Tumor Suppressor Proteins	2011
Targeting the endothelin axis in prostate carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:2 Topics: Atrasentan; Bone and Bones; Carcinoma; Cell Proliferation; Clinical Trials as Topic; Endothelins; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Prostatic Neoplasms; Pyrrolidines	2012
Role of quality of life in men with metastatic hormone-refractory prostate cancer: how does atrasentan influence quality of life? European urology, 2006, Volume: 49, Issue:5 Topics: Atrasentan; Drug Resistance, Neoplasm; Endothelin-1; Gonadal Steroid Hormones; Humans; Male; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms; Pyrrolidines; Quality of Life	2006

Trials

4 trial(s) available for atrasentan and Neoplasm Metastasis

Article	Year
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-01, Volume: 14, Issue:19 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Taxoids; Treatment Outcome	2008
Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma. British journal of cancer, 2012, Jan-17, Volume: 106, Issue:2 Topics: Adult; Aged; Atrasentan; Carcinoma, Renal Cell; Cohort Studies; Drug Therapy, Combination; Endothelins; Female; Humans; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pyrrolidines	2012
Clinical trials of atrasentan in hormone-refractory prostate cancer. Clinical prostate cancer, 2003, Volume: 2, Issue:2 Topics: Atrasentan; Disease Progression; Double-Blind Method; Endothelin-1; Humans; Male; Neoplasm Metastasis; Pain; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrrolidines; Quality of Life; Survival Analysis; Treatment Outcome	2003
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer, 2006, Aug-01, Volume: 107, Issue:3 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Disease Progression; Dyspnea; Edema; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Treatment Outcome; Zoledronic Acid	2006

Other Studies

2 other study(ies) available for atrasentan and Neoplasm Metastasis

Article	Year
Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells. International journal of cancer, 2010, Aug-01, Volume: 127, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atrasentan; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Synergism; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Genes, erbB-2; Humans; Neoplasm Metastasis; Phosphorylation; Pyrrolidines; Receptor, Endothelin A; Trastuzumab	2010
Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer research, 1996, Feb-15, Volume: 56, Issue:4 Topics: Apoptosis; Atrasentan; Base Sequence; Cell Division; Cell Line; Culture Media, Serum-Free; DNA Primers; DNA, Neoplasm; Endothelin Receptor Antagonists; Endothelins; Epidermal Growth Factor; Fibroblast Growth Factor 2; Gene Expression; Growth Substances; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Mitotic Index; Molecular Sequence Data; Neoplasm Metastasis; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Tumor Cells, Cultured	1996

Article

Year

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.

International journal of cancer, 2010, Aug-01, Volume: 127, Issue:3

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atrasentan; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Synergism; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Genes, erbB-2; Humans; Neoplasm Metastasis; Phosphorylation; Pyrrolidines; Receptor, Endothelin A; Trastuzumab

2010

Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.

Cancer research, 1996, Feb-15, Volume: 56, Issue:4

Topics: Apoptosis; Atrasentan; Base Sequence; Cell Division; Cell Line; Culture Media, Serum-Free; DNA Primers; DNA, Neoplasm; Endothelin Receptor Antagonists; Endothelins; Epidermal Growth Factor; Fibroblast Growth Factor 2; Gene Expression; Growth Substances; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Mitotic Index; Molecular Sequence Data; Neoplasm Metastasis; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Pyrrolidines; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Tumor Cells, Cultured

1996